Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

Researchers created a simple tool to predict bladder blockage from prostate enlargement using urine flow rate and prostate volume.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Using tamsulosin and finasteride together for benign prostatic syndrome has increased and shows improvement in symptoms, but more reliable comparisons are needed.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Certain drugs that block specific enzymes can help treat prostate diseases.

Men's age, urinary symptoms, and heart health risks create different types of erectile dysfunction.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Ganoderma lucidum may help treat enlarged prostate in rats.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.